Scotia Pharmaceuticals other research news

The Surrey, U.K., company reported preclinical findings of synergistic action of lithium gamma-linolenate with other chemotherapeutics.

The compound also restored responsiveness in cells that have become resistant to chemotherapeutics. Cells were exposed for four days continuously to the agent. Pretreatment with the agent enhanced by 40-50 percent the toxicity of carboplatin and vincristine. ...